{"nct_id":"NCT01423058","title":"Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis","status":"COMPLETED","status_verified_date":"2019-01","start_date":"2011-08","start_date_type":null,"primary_completion_date":"2014-06","primary_completion_date_type":"ACTUAL","completion_date":"2014-06","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}